Invest. Engage. Save.

Rss

California, Here We Come!

Posted by: BIO Ventures for Global Health on 7/20/2010 | 1 Comment
We’re heading west! This week BIO Ventures for Global Health (BVGH) announced that it is opening a new headquarters office in the heart of the San Francisco financial district. As we work to attract new companies to global health and guide companies already working in the space, we rely on our discussions with biotech leaders to help shape programs and strategies.
Categories: News

Jumping to Conclusions

Posted by: BIO Ventures for Global Health on 7/6/2010 | 0 Comments
Have PRVs failed? Some of the recent articles about the FDA’s Office of Orphan Drug Products push for drug companies to examine existing medicines for potential benefits for rare disorders would like you to think so. Guess what? They’re wrong.
Categories: Incentives

Moving Forward

Posted by: BIO Ventures for Global Health on 6/28/2010 | 1 Comment
Last week BVGH CEO Melinda Moree attended a meeting in Brussels called by the European Union on Global Health. These high-level meetings seem largely ceremonial but obtaining consensus and inter-governmental agreement is key to enabling large organizations to move forward. So, they are frustrating but necessary.
Categories: Meetings

Coming Out of the Dark

Posted by: BIO Ventures for Global Health on 6/21/2010 | 2 Comments
Last Wednesday, I had the opportunity to see Ricardo Preve’s documentary “Chagas: A Hidden Affliction” at a screening in Washington, DC. Preve, a filmmaker who hails from the Chagas-endemic northwest region of Argentina, made this movie to raise awareness after a friend was diagnosed with the disease. I loved the film, but it brought home to me how many people are unaware of Chagas disease. The opening segment portrays individuals being approached Michael Moore-style by the camera crew in Charlottesville, VA
Categories: News

On the Market

Posted by: BIO Ventures for Global Health on 6/8/2010 | 0 Comments
In this economy, vibrant may not be the first word you think of when assessing the life sciences. The recession affected the industry worldwide, drying up venture capital funding and making lucrative IPOs a thing of the past. But things are starting to look up, and according to Prithviraj Chavan, Minister for Science and Technology and Earth Sciences of India, vibrant is exactly the word to describe today’s Indian life sciences sector.

Help Us, Help You

Posted by: BIO Ventures for Global Health on 5/24/2010 | 0 Comments
More funding is needed for research and development for drugs, vaccines, and diagnostics to combat neglected diseases. It’s a statement that BIO Ventures for Global Health (BVGH) makes often and the key assumption that underlies our very existence as an organization. How do we know that it’s true? The G-FINDER report is one source.
Categories: News

The Ten Billion Dollar Question

Posted by: BIO Ventures for Global Health on 5/5/2010 | 0 Comments
Bill and Melinda Gates recently pledged $10 billion over the next ten years to vaccines, creating the “decade of vaccines.” The ten billion dollar question, of course, is what will the Foundation do with these funds? Read more about a session at BIO where this question was discussed.
Categories: Incentives Meetings

North-South Partnership

Posted by: BIO Ventures for Global Health on 5/3/2010 | 0 Comments
Emerging markets are fast becoming a global health research and development powerhouse. Just ask Dr. Mamphela Ramphele of South Africa's Technology Innovation Agency. At yesterday's Partnering for Global Health Forum, she said that global health R&D is not simply a question of what the 'North can do for the South,' but what the North and the South can partner to achieve to fast track the development of new drugs and to mine the huge markets that are opening up. Read more...
Categories: Meetings Partnering

A Novel Conversation

Posted by: BIO Ventures for Global Health on 5/3/2010 | 0 Comments
Investors understand the demand for malaria or HIV vaccines. A company working in the field of anthrax will do well because the investor clearly sees that the U.S. government has a firm commitment to buy a vaccine. But how do you explain to investors about a market commitment for a small, specific neglected disease target?
Categories: Incentives Meetings

Don't Blame the Market

Posted by: BIO Ventures for Global Health on 5/3/2010 | 0 Comments
During our luncheon plenary, Dr. Nils Daulaire from the U.S. Dept. of Health and Human Services said that we are not looking at failure, but rather the natural workings of the market, where you have customers who cannot afford to purchase medicines. Rather than talk about failure, we must talk about ways to get around developing world limitations with something more than the invisible hand. Read more...
Categories: Meetings News Partnering
Page: 1 2 3 4 5  | Go to Page:

  
  

Recent Comments

by over50dating on California, Here We Come!
"Greatpost...thanks for sharing such a wonderful writeup" Read more »

by 0nline dating on Speed Dating to Save Lives
"That's pretty interesting... That's great, I never thought about Speed Dating to Save Lives like that before. " Read more »

by Over 50 Dating on Speed Dating to Save Lives
"Speed dating is rightly the order of the day, especially as time and managing resources are two prime concerns today! " Read more »

  

Tag Cloud